Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
110
Views
23
CrossRef citations to date
0
Altmetric
Case Series

ALK-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature

Qiang Zheng1 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China, [email protected];2 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China, [email protected]
,
Mingjia Zheng1 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China, [email protected];2 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China, [email protected]
,
Yan Jin1 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China, [email protected];2 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China, [email protected]
,
Xuxia Shen1 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China, [email protected];2 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China, [email protected]
,
Ling Shan1 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China, [email protected];2 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China, [email protected]
,
Lei Shen1 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China, [email protected];2 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China, [email protected]
,
Yihua Sun2 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China, [email protected];3 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
,
Haiquan Chen2 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China, [email protected];3 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
&
Yuan Li1 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China, [email protected];2 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China, [email protected]Correspondence[email protected]
 show all
Pages 4991-4998 | Published online: 17 Aug 2018

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gitte Dam, Henning Grønbæk, Anna Sundlöv, Johan Botling, Anders Sundin, Rene Horsleben Petersen, Staffan Welin, Espen-Thiis Evensen, Halfdan Sorbye, Elizaveta Tabaksblat, Anne Kirstine Arveschoug, Jann Mortensen, Andreas Kjaer, Ulrich Knigge, Eva Tiensuu Janson & Seppo W. Langer. (2023) Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms. Acta Oncologica 62:5, pages 431-437.
Read now
Na Liu, Jingjing Wang, Xiao Fu, Xiaoqiang Zheng, Huan Gao, Tao Tian, Zhiping Ruan & Yu Yao. (2020) A case of primary pulmonary atypical carcinoid with EML4-ALK rearrangement. Cancer Biology & Therapy 21:1, pages 12-16.
Read now

Articles from other publishers (21)

Bipin Ghimire, Ashbita Pokharel, Ujjwal Karki, Shrinjaya Thapa & Mohammad Muhsin Chisti. (2023) Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor). Clinical Lung Cancer 24:3, pages e113-e116.
Crossref
Gianluca Ricco, Renata Seminerio, Elisa Andrini, Deborah Malvi, Elisa Gruppioni, Annalisa Altimari, Stefano Zagnoni, Davide Campana & Giuseppe Lamberti. (2023) BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature. Anti-Cancer Drugs Publish Ahead of Print.
Crossref
Dilara Akhoundova, Martina Haberecker, Ralph Fritsch, Sylvia Höller, Michael K. Kiessling, Markus Rechsteiner, Jan H. Rüschoff & Alessandra Curioni-Fontecedro. (2022) Targeting ALK in Neuroendocrine Tumors of the Lung. Frontiers in Oncology 12.
Crossref
Zaixiang Fu, Ganggui Zhu, Liquan Wang, Shen Hu, Lu Cheng & Fuyi Liu. (2022) Case Report: A Pregnant Woman Diagnosed as ALK-Rearrangement Lung Large Cell Neuroendocrine Cancer With Brain Metastasis. Frontiers in Oncology 12.
Crossref
Denise A Gococo-Benore, Ashton Boyle, Natasha Wylie, Leylah Drusbosky, Andras Khoor & Jason S Starr. (2022) Atypical Lung Carcinoid With EML4/ALK Fusion Detected With Circulating Tumor DNA. Cureus.
Crossref
Michele Prisciandaro, Maria Antista, Alessandra Raimondi, Francesca Corti, Federica Morano, Giovanni Centonze, Giovanna Sabella, Alessandro Mangogna, Giovanni Randon, Filippo Pagani, Natalie Prinzi, Monica Niger, Salvatore Corallo, Erica Castiglioni di Caronno, Marco Massafra, Maria Di Bartolomeo, Filippo de Braud, Massimo Milione & Sara Pusceddu. (2022) Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective. Frontiers in Oncology 12.
Crossref
Chloe A. Lim, Norbert Banyi, Tracy Tucker, Diana N. Ionescu & Barbara Melosky. (2022) A Case of ALK-Rearranged Combined Lung Adenocarcinoma and Neuroendocrine Carcinoma with Diffuse Bone Metastasis and Partial Response to Alectinib. Current Oncology 29:2, pages 848-852.
Crossref
Helene Doubre, Severine Fraboulet, Elisabeth Longchampt, Diane Damotte, Audrey Lupo, Louis-Jean Couderc, Matthieu Glorion & Segolene Hescot. (2021) ALK Rearrangement in Lung Neuroendocrine Neoplasms: Case Series of Non-Asian Patients With Response to ALK Inhibitors. Clinical Lung Cancer 22:5, pages e686-e690.
Crossref
Kazuki Masuda, Masafumi Saiki, So Shimamura, Shuichiro Ide, Yoshinori Uchida, Yusuke Sogami, Hiroshi Ishihara, Fumi Ikeda & Kiyotaka Kugiyama. (2021) Dramatic response to alectinib in an ALK ‐positive LCNEC patient with a poor performance status: A case report . Respirology Case Reports 9:9.
Crossref
Virginia Corbett, Susanne Arnold, Lowell Anthony & Aman Chauhan. (2021) Management of Large Cell Neuroendocrine Carcinoma. Frontiers in Oncology 11.
Crossref
Shuai Wang, Xuan Wu, Jiuzhou Zhao, Haiyang Chen, Zhe Zhang, Mingyue Wang, Cong Xu, Yongsen Wang, Lili Wang, Zhen He & Qiming Wang. (2021) Next-Generation Sequencing Identified a Novel Crizotinib-Sensitive PLB1-ALK Rearrangement in Lung Large-Cell Neuroendocrine Carcinoma. Clinical Lung Cancer 22:3, pages e366-e370.
Crossref
Masayo Yoshimura, Kurumi Seki, Andrey Bychkov & Junya Fukuoka. (2021) Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments. Frontiers in Oncology 11.
Crossref
Takahiro Tashiro, Kosuke Imamura, Yusuke Tomita, Daisuke Tamanoi, Akira Takaki, Kazuaki Sugahara, Ryo Sato, Koichi Saruwatari, Shinya Sakata, Megumi Inaba, Sunao Ushijima, Naomi Hirata & Takuro Sakagami. (2020) Heterogeneous Tumor-Immune Microenvironments between Primary and Metastatic Tumors in a Patient with ALK Rearrangement-Positive Large Cell Neuroendocrine Carcinoma. International Journal of Molecular Sciences 21:24, pages 9705.
Crossref
Aline F. Fares, Benjamin H. Lok, Tong Zhang, Michael Cabanero, Sally C.M. Lau, Tracy Stockley, Devalben Patel, Penelope A. Bradbury, Adrian Sacher, Kazuhiro Yasufuku, Barbara A. Morash, Peter J.B. Sabatini, Lananhn N. Nguyen, Natasha B. Leighl, Ming-Sound Tsao, Frances A. Shepherd, Geoffrey Liu, Sebastiao N. Martins-Filho & Prodipto Pal. (2020) ALK-rearranged lung adenocarcinoma transformation into high-grade large cell neuroendocrine carcinoma: Clinical and molecular description of two cases. Lung Cancer 146, pages 350-354.
Crossref
Jose Luis Leal, Geoffrey Peters, Marcin Szaumkessel, Trishe Leong, Khashayar Asadi, Gareth Rivalland, Hongdo Do, Clare Senko, Paul L. Mitchell, Chai Zi Quing, Alexander Dobrovic, Bibhusal Thapa & Thomas John. (2020) NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer. Lung Cancer 146, pages 154-159.
Crossref
Oscar Lopez-Nunez, Ivy John, Ryane N. Panasiti, Sarangarajan Ranganathan, Luisa Santoro, Diane Grélaud, Tao Wu, Anna Maria Buccoliero, Michela Casanova, Rita Alaggio & Lea F. Surrey. (2020) Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases. Modern Pathology 33:4, pages 576-590.
Crossref
Georgios Ioannidis. (2020) Pulmonary Large-Cell Neuroendocrine Carcinoma: Therapeutic Challenges and Opportunities. Forum of Clinical Oncology 11:1, pages 7-21.
Crossref
Youhei Takahashi, Yuta Sudo, Yuichiro Asai, Koji Kuronuma, Hirofumi Chiba & Hiroki Takahashi. (2019) Successful Treatment of Anaplastic Lymphoma Kinase (<i>ALK</i>)-rearrangement Atypical Carcinoid of the Lung with an<i> ALK</i> Inhibitor: a Case Report<i>ALK</i>阻害薬が奏効した<i>ALK</i>融合遺伝子陽性肺異型カルチノイドの1例. Haigan 59:7, pages 1171-1176.
Crossref
Mariangela Torniai, Laura Scortichini, Francesca Tronconi, Corrado Rubini, Francesca Morgese, Silvia Rinaldi, Paola Mazzanti & Rossana Berardi. (2019) Systemic treatment for lung carcinoids: from bench to bedside. Clinical and Translational Medicine 8:1.
Crossref
Julian Pinsolle, Julie Mondet, Michael Duruisseaux, Ségolène d'Alnoncourt, Nelly Magnat, Florence de Fraipont, Denis Moro-Sibilot, Anne-Claire Toffart, Elisabeth Brambilla & Anne McLeer-Florin. (2019) A Rare Fusion of CLIP1 and ALK in a Case of Non–Small-Cell Lung Cancer With Neuroendocrine Features. Clinical Lung Cancer 20:5, pages e535-e540.
Crossref
Ye Wang, Panwen Tian, Weiya Wang, Yalun Li, Yu Wang & Weimin Li. (2019) A case of large-cell neuroendocrine carcinoma harboring rare ALK fusion with initial response to the ALK inhibitor crizotinib and acquired F1174L mutation after resistance. Precision Clinical Medicine 2:1, pages 1-5.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.